Advertisement

Advertisement

ADVERTISEMENT

Poll

Poll: Screening for Bone Loss in Patients With GI Disorders

08/25/2020

Want to tell us more? Submit your feedback via the box below. For more IBD content, visit our Resource Center.

Advertisement

Advertisement

Popular Articles

R Balfour Sartor, MD, on New Insights Into the Microbiome and IMIDs

Videos

R Balfour Sartor, MD, on New Insights Into the Microbiome and IMIDs

04/16/2021

In this video, Dr Sartor, from the University of North Carolina at Chapel Hill, discusses the role of bacteria and other organisms in the microbiome and how a variety of therapies, from biologic therapies to fecal microbiota transplantation,...

In this video, Dr Sartor, from the University of North Carolina at Chapel Hill, discusses the role of bacteria and other organisms in the microbiome and how a variety of therapies, from biologic therapies to fecal microbiota transplantation,...

In this video, Dr Sartor, from...

04/16/2021

Autoimmune

Dermatology

John E. Harris, MD, on What Autoimmune Specialists Should Know About Vitiligo

06/21/2021

Did you know that World Vitiligo Day is June 25? John E. Harris, MD, PhD, shares what autoimmune specialists should know about vitiligo and how it can negatively impact patient quality of life due to its visible dyspigmentation. Dr Harris is...

Did you know that World Vitiligo Day is June 25? John E. Harris, MD, PhD, shares what autoimmune specialists should know about vitiligo and how it can negatively impact patient quality of life due to its visible dyspigmentation. Dr Harris is...

Did you know that World Vitiligo...

06/21/2021

Autoimmune

Sponsored

Charting the Course Toward Improved Patient Outcomes in Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA)

11/10/2023

In this white paper, leading experts in the treatment of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) summarize the educational gaps among health care providers that are preventing optimal patient care....

In this white paper, leading experts in the treatment of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) summarize the educational gaps among health care providers that are preventing optimal patient care....

In this white paper, leading...

11/10/2023

Dermatology

News

Interleukin Inhibitors Effective Among TNFi-Exposed Patients With PsA

05/16/2022

Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.

Investigators set out to determine if interleukin-17 and -12/23 inhibitors were effective among patients with psoriatic disease who responded inadequately to tumor necrosis factor inhibitors.

Investigators set out to...

05/16/2022

Rheumatology & Arthritis

News

Research Looks at Infection Risks Among Biologics for PsO and PsA

11/11/2021

Meta-analysis shows that serious infection rates are lower among patients treated with ustekinumab.

Meta-analysis shows that serious infection rates are lower among patients treated with ustekinumab.

Meta-analysis shows that serious...

11/11/2021

Autoimmune

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement